BioTech Mag Search: Research
Mammalian cell cultivation using nutrients extracted from microalgae
1 day ago - By Wiley
Abstract
Mammalian cells have been used in various research fields. More recently, cultured cells have been used as the cell source of “cultured meat.” Cell cultivation requires media containing nutrients, of which glucose and amino acids are the essential ones. These nutrients are generally derived from grains or heterotrophic microorganisms, which also require various nutrients derived from grains. Grain culture, in turn, requires many chemical fertilizers and agrochemicals, which can cause greenhouse gas emission and environmental contamination. Furthermore, grain production is greatly...
Read more ...SH‐SY5Y and LUHMES cells display differential sensitivity to MPP+, tunicamycin and epoxomicin in 2D and 3D cell culture
1 day ago - By Wiley
Abstract
SH‐SY5Y and LUHMES cell lines are widely used as model systems for studying neurotoxicity. Most of the existing data regarding the sensitivity of these cell lines to neurotoxicants have been recorded from cells growing as two‐dimensional cultures on the surface of glass or plastic. With the emergence of three‐dimensional culture platforms designed to better represent native tissue, there is a growing need to compare the toxicology of neurons grown in 3D environments to those grown in 2D to better understand the impact that culture environment has on toxicant sensitivity. Here, a...
Read more ...
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
An experimental Sage Therapeutics drug intended to alleviate depression symptoms quickly has failed to beat a placebo in a pivotal study, the company reported Thursday...
FDA Rejects Enzyvant's Regenerative Therapy for Rare Immune Disorder
The FDA has rejected an experimental regenerative therapy that Enzyvant developed to restore immune system function in babies born with a rare disorder. The agency cited...
As Alzheimer's Conference Kicks Off, All Eyes Are on Biogen's Drug
It's the “era of neuroscience”; an industry “turning point”; and “an amazing time”-superlatives were flowing freely as the 11th annual Clinical Trials on Alzheimer's Disease...
6 Experimental Alzheimer's Disease Diagnostics Projects Get Funding Boost
Scientists gathered this week in San Diego at the annual Clinical Trials on Alzheimer's Disease Congress are focused on ways to treat the neurodegenerative disease, a task that...
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding
New biotech company Civetta Therapeutics has closed a $53 million Series A financing round to develop drugs that target “propeller proteins” as a way of treating cancers and...
Freeze Frame: Scientists Capture Atomic-Scale Snapshots of Artificial Proteins
Berkeley Lab scientists employed cryogenic electron microscopy to reveal the atomic structure of peptoid nanosheets. Their use of cryo-EM allowed them to visualize distinct...
Award-Winning Sequel II System Sets a New Standard for Long-Read Sequencing
Every year since 2008, The Scientist has canvassed the life-science community to find out which newly released products are having the biggest impact on research. We were proud...
FDA Green Lights Sight Diagnostics' Finger-Prick Blood Test
Sight Diagnostics today announced it has received US FDA 510 clearance to use its patented OLO analyzer, which performs a complete blood count using two drops of blood. The FDA...
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck
A Roche immunotherapy has won an additional FDA approval as a first-line treatment for non-small lung cancer, bolstering the product's competitive stance versus one from Merck...
GHO Capital raises over $1bn, Eyes Biotech Outsourcing Services
GHO Capital will use the money raised to invest in healthcare, including outsourced service providers, which are seeing demand from smaller biotechs, according to a Jefferies...